World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
18115
World Ranking
17749
National Ranking
8857

Sharyn D. Baker publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sharyn D. Baker sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 347 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sharyn D. Baker D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sharyn D. Baker sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sharyn D. Baker is affiliated with The Ohio State University in the United States and has a substantial publication record primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research covers significant subfields including Hematology, Molecular Biology, Oncology, Genetics, and Pharmacology.

Their recent papers address a variety of topics and have been published in well-regarded venues:

  • "A new genomic framework to categorize pediatric acute myeloid leukemia" (2024), Nature Genetics
  • "Targeting OCT3 attenuates doxorubicin-induced cardiac injury" (2021), Proceedings of the National Academy of Sciences
  • "A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury" (2020), Nature Communications
  • "Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions" (2021), Basic & Clinical Pharmacology & Toxicology
  • "Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors" (2020), Pharmaceutics

Baker frequently collaborates with other researchers, with the most common coauthors including:

  • Alex Sparreboom (44 joint publications)
  • Eric D. Eisenmann (34 joint publications)
  • Daelynn R. Buelow (29 joint publications)
  • Shelley Orwick (20 joint publications)
  • Yan Jin (16 joint publications)

Baker's publications often appear in select journals noted for research in pharmacology, hematology, and molecular biology:

  • Journal of Pharmacology and Experimental Therapeutics (10 publications)
  • Blood (10 publications)
  • Journal of Chromatography B (5 publications)
  • The FASEB Journal (5 publications)
  • Pharmaceutics (4 publications)

Their main research topics concentrate on Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Drug Transport and Resistance Mechanisms, Chronic Lymphocytic Leukemia Research, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, and Protein Degradation and Inhibitors. These subjects align with the breadth of their published work and indicate a consistent focus on hematologic cancers, drug mechanisms, and molecular biology of disease.

Best Publications

  • The genomic landscape of hypodiploid acute lymphoblastic leukemia

    Linda Holmfeldt;Lei Wei;Ernesto Diaz-Flores;Michael Walsh

  • CREBBP mutations in relapsed acute lymphoblastic leukaemia

    Charles G. Mullighan;Jinghui Zhang;Lawryn H. Kasper;Stephanie Lerach

  • Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.

    Clet Niyikiza;Sharyn D Baker;David E Seitz;Jackie M Walling

  • Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes

    Jing Li;Ming Zhao;Ping He;Manuel Hidalgo

  • Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001

    Sharyn D. Baker;Jaap Verweij;Eric K. Rowinsky;Ross C. Donehower

  • Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

    Ron H. J. Mathijssen;Sharon Marsh;Mats O. Karlsson;Rujia Xie

  • An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors

    Maria L. Amador;Darin Oppenheimer;Sofia Perea;Anirban Maitra

  • A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.

    Jill Gilbert;Sharyn D. Baker;M. Katherine Bowling;Louise Grochow

  • Absorption, Metabolism, and Excretion of 14C-Temozolomide following Oral Administration to Patients with Advanced Cancer

    Sharyn D. Baker;Sharyn D. Baker;Mark Wirth;Paul Statkevich;Pascale Reidenberg

  • Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib

    George Cusatis;Vanesa Gregorc;Jing Li;Anna Spreafico

  • Interaction of Imatinib with Human Organic Ion Carriers

    Shuiying Hu;Ryan M. Franke;Kelly K. Filipski;Kelly K. Filipski;Chaoxin Hu

  • Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

    Matthews O. Bradley;Nigel L. Webb;Forrest H. Anthony;Prabu Devanesan

  • Clinical pharmacokinetics of docetaxel : recent developments.

    Sharyn D. Baker;Alex Sparreboom;Jaap Verweij

  • A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation.

    David A. Rinaldi;John G. Kuhn;Howard A. Burris;F. Andrew Dorr

  • Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients.

    Jing Li;George Cusatis;Julie Brahmer;Alex Sparreboom

  • The Influence of Protein Binding upon Tissue Fluid Levels of Six β-Lactam Antibiotics

    R. Wise;A. P. Gillett;B. Cadge;S. R. Durham

  • Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

    Eric I. Zimmerman;David C. Turner;Jassada Buaboonnam;Shuiying Hu

  • Pharmacogenetic pathway analysis of docetaxel elimination.

    SD Baker;J Verweij;GA Cusatis;RH van Schaik

  • Evaluation of Alternate Size Descriptors for Dose Calculation of Anticancer Drugs in the Obese

    Alex Sparreboom;Antonio C. Wolff;Ron H.J. Mathijssen;Etienne Chatelut

  • Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters

    Shuiying Hu;Zhaoyuan Chen;Ryan Franke;Shelley Orwick

Frequent Co-Authors

Alex Sparreboom
Alex Sparreboom The Ohio State University
Jeffrey E. Rubnitz
Jeffrey E. Rubnitz St. Jude Children's Research Hospital
Ross C. Donehower
Ross C. Donehower Johns Hopkins University
Jaap Verweij
Jaap Verweij Erasmus University Rotterdam
Michael A. Carducci
Michael A. Carducci Johns Hopkins University
Manuel Hidalgo
Manuel Hidalgo Cornell University
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Stanley Pounds
Stanley Pounds St. Jude Children's Research Hospital
Wells A. Messersmith
Wells A. Messersmith University of Colorado Boulder
Eric K. Rowinsky
Eric K. Rowinsky Eli Lilly (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering alternative or complementary pathways to studying Medicine in the USA? There are a variety of accredited online nursing and healthcare degrees that provide fast and flexible options for advancing your medical career.

For those seeking a terminal nursing degree, the quickest dnp program options can dramatically reduce study time while enhancing clinical leadership skills. If research and lengthy dissertations are a concern, many students opt for online dnp programs without dissertation requirements, streamlining the path to a doctorate in nursing.

Entry-level healthcare professionals can explore fast track lpn programs to quickly start working in the medical field. Meanwhile, registered nurses interested in mental health can pursue fast track mental health nursing pathways to specialize faster than traditional routes.

These online programs offer greater flexibility, allowing you to balance work and study while accessing in-demand healthcare roles. Whether you’re just starting or looking to specialize, these alternative pathways can help you achieve your career goals efficiently.

Best Scientists Citing Sharyn D. Baker

Trending Scientists